Cargando...
Bone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myeloma
Skeletal lesions contribute substantially to morbidity and mortality in patients with cancer. The disease manifestation course during metastatic bone disease is driven by tumour cells in the bone marrow, which alter the functions of bone-resorbing (osteoclasts) and bone-forming (osteoblasts) cells,...
Guardado en:
| Publicado en: | Bonekey Rep |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4606491/ https://ncbi.nlm.nih.gov/pubmed/26512321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bonekey.2015.113 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|